Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma
NCT00287976
Interventional
Phase 2
Unknown status
RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well irinotecan works in treating young patients with refractory or recurrent hepatoblastoma.
Apr 30,2003
All
N/A
20 Years
N/A
20 Years
30